Cobimetinib
98%
- Product Code: 124732
CAS:
934660-93-2
| Molecular Weight: | 531.3200000000001 g./mol | Molecular Formula: | C₂₁H₂₁F₃IN₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22124461 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Cobimetinib is primarily used in the treatment of certain types of cancer, particularly melanoma. It is often prescribed in combination with another drug, vemurafenib, to enhance its effectiveness. This combination therapy targets specific genetic mutations in cancer cells, helping to slow down or stop the growth of tumors. It is especially effective for patients whose melanoma has a mutation in the BRAF gene. The drug works by inhibiting the activity of enzymes that promote cancer cell proliferation, making it a valuable option in targeted cancer therapy. Regular monitoring and management of potential side effects are essential during treatment.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Powder Or Crystals |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $391.76 |
+
-
|
| 0.025 | 10-20 days | $632.85 |
+
-
|
| 0.100 | 10-20 days | $1,637.37 |
+
-
|
Cobimetinib
Cobimetinib is primarily used in the treatment of certain types of cancer, particularly melanoma. It is often prescribed in combination with another drug, vemurafenib, to enhance its effectiveness. This combination therapy targets specific genetic mutations in cancer cells, helping to slow down or stop the growth of tumors. It is especially effective for patients whose melanoma has a mutation in the BRAF gene. The drug works by inhibiting the activity of enzymes that promote cancer cell proliferation, making it a valuable option in targeted cancer therapy. Regular monitoring and management of potential side effects are essential during treatment.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :